Dr. Sanjay Gupta is the multiple Emmy®-award winning chief medical correspondent for CNN and host of the CNN podcast Chasing Life. Gupta, a practicing neurosurgeon, plays an integral role in CNN’s reporting on health and medical news for all of CNN’s shows domestically and internationally, and regularly contributes to CNN.com.
Since 2001, Gupta has covered some of the most important health stories in the United States and around the world. On March 9, 2020, Gupta penned an op-ed announcing the network would refer to the novel coronavirus outbreak as a “pandemic,” ahead of both the WHO and the CDC. Throughout 2020 into 2021, Gupta reaffirmed his role as a trusted guide to viewers worldwide on navigating between facts and fiction surrounding Covid-19 and the pandemic.
Dr. Muge Cevik is a clinical lecturer in infectious diseases and medical virology. Her research interests focus on HIV, tuberculosis, other tropical infections and emerging infections including Covid-19 since the beginning of 2020.
During the Covid-19 pandemic, as well as working on the NHS front line of the response, Dr Cevik provided scientific advice to the Chief Medical Officer – Scotland and advisory groups on recent scientific developments on Covid-19. She has been co-opted to NERVTAG (New and Emerging Respiratory Virus Threats Advisory Group) as a member for Covid-19, advising and producing guidance documents for UK-SAGE (Scientific Advisory Group for Emergencies). She also provided advice and consultancy to the World Health Organisation (WHO) on risk communication during Covid-19 pandemic.
Dr Cevik is also coordinating the recruitment of hospitalised COVID-19 patients in South East Asia and South Africa working closely with the International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC) funded by the Wellcome Trust. Additionally, she is co-leading a household transmission study in Scotland as well as a prospective study to quantify the burden of Covid-19 in patients with tuberculosis in Kampala, Uganda, with support from GCRF-NIHR. She is part of the CORRE Network (Covid-19 International Rapid Evidence Reviews Group) working towards providing rapid reviews for governments and the WHO.
Alongside her academic work, Dr Cevik developed a strong interest in science communication. She is passionate about the value of integrating science communication into our efforts to disseminate research, which has the potential to enhance knowledge exchange among scientists and physicians, and the broader public.
Baruch Fischhoff is Howard Heinz University Professor, Department of Engineering and Public Policy and Institute for Politics and Strategy, Carnegie Mellon University. A graduate of the Detroit Public Schools, he holds a BS (mathematics, psychology) from Wayne State University and a PhD (psychology) from the Hebrew University of Jerusalem. He is a member of the National Academy of Sciences and the National Academy of Medicine. He is past President of the Society for Judgment and Decision Making and of the Society for Risk Analysis. He has chaired the FDA Risk Communication Advisory Committee and been a member of the Eugene (Oregon) Commission on the Rights of Women, the DHS Science and Technology Advisory Committee and the EPA Scientific Advisory Board, where he chaired the Homeland Security Advisory Committee. He has received the American Psychological Association (APA) Award for Distinguished Contribution to Psychology, Carnegie Mellon’s Ryan Award for Meritorious Teaching, a Doctorate of Humanities honoris causa from Lund University, an Andrew Carnegie Fellowship, and Sigma Xi William Procter Prize for Scientific Achievement. He is a Fellow of APA, the American Association for the Advancement of Science, the Association for Psychological Science, Society of Experimental Psychologists, and Society for Risk Analysis. His books include Acceptable Risk (1981), A Two-State Solution in the Middle East (1993), Risk: A Very Short Introduction (2011), Communicating Risks and Benefits (2011) and Counting Civilian Casualties (2013). He has served on many committees of the National Academies, including recent ones on science communication, intelligence analysis, cybersecurity, global change, and pandemic disease.
PC: Rachel Hulin
Emily Oster is a Professor of Economics at Brown University and the author of The Family Firm: A Data-Driven Guide to Better Decision Making in the Early School Years, Cribsheet: A Data-Driven Guide to Better, More Relaxed Parenting, from Birth to Preschool, and Expecting Better: Why the Conventional Pregnancy Wisdom Is Wrong–and What You Really Need to Know. She writes the newsletter ParentData and her work has been featured in The New York Times, The Wall Street Journal, The Washington Post, The Atlantic, and Bloomberg. She has two children.
David Leonhardt is a senior writer for The New York Times. He writes The Morning, The Times’s flagship daily newsletter, and also writes for Sunday Review.
He has worked at The Times since 1999 and has previously been an Op-Ed columnist, Washington bureau chief, co-host of “The Argument” podcast, founding editor of The Upshot section and a staff writer for The Times Magazine. He also led a strategy group that helped Times leadership shape the newsroom’s digital future.
In 2011, he received the Pulitzer Prize for commentary. He is a third-generation native of New York City.
Dr. Rowley is Professor of Pediatrics and of Microbiology/Immunology at Northwestern University Feinberg School of Medicine and an Attending Physician in the Division of Infectious Diseases at the Ann & Robert H. Lurie Children’s Hospital of Chicago. She has devoted most of her research career to the study of the immunology, pathology, and pathogenesis of Kawasaki disease. The title of her talk is “Cloning the Plasmablast Response to Solve the Mystery of Kawasaki Disease Pathogenesis.”
Daniel Diekema, MD, MS is a Professor of Internal Medicine and Pathology at the University of Iowa Carver College of Medicine, where he served as the Director of the Division of Infectious Diseases from 2010-2021. He is the Associate Director of the Clinical Microbiology Laboratory and Hospital Epidemiologist at the University of Iowa Healthcare. Dr. Diekema received his medical degree from Vanderbilt University, completed a residency in Internal Medicine at the University of Virginia and fellowships in Infectious Diseases and Medical Microbiology at the University of Iowa, where he also earned a Masters of Science in Preventive Medicine. His clinical and research interests include the epidemiology of healthcare-associated infections and antimicrobial resistance and the role of the diagnostic laboratory in infection prevention and antimicrobial stewardship. He has previously served as the co-chair of the Healthcare Infection Control Practices Advisory Committee (HICPAC), the federal advisory committee that provides recommendations to the Centers for Disease Control and Prevention, and is a past president of the Society for Healthcare Epidemiology of America (SHEA).
Dr. Bottazzi is associate dean of the National School of Tropical Medicine; professor of pediatrics, molecular virology and microbiology, division chief of pediatric tropical medicine and co-director of Texas Children’s Center for Vaccine Development at Baylor College of Medicine in Houston; and distinguished professor in biology at Baylor University in Waco.
She pioneers and leads the advancement of a robust infectious and tropical disease vaccine portfolio, tackling diseases that disproportionally affect the world’s poorest populations, such as coronavirus, hookworm, schistosomiasis and Chagas. Dr. Bottazzi will present “Decolonizing the Vaccine Sciences: Tropical Medicine Catalyzing Change.”
Dr. Bell is an Assistant Professor of Medicine in the divisions of Infectious Disease and Pulmonary/Critical Care Medicine at the University of Virginia. He is also the Vice Chair for Faculty Development in the Department of Medicine and Director of the UVA Summer Medical Leadership Program (a medical school preparatory program for under-represented and disadvantaged students). Dr. Bell joined the faculty in 2017 after completing a critical care fellowship at the National Institutes of Health. Prior to that he completed internal medicine residency at the Massachusetts General Hospital—where he was as chief resident—and infectious disease fellowship at Mass General Brigham. Dr. Bell is co-founder and Chief Medical Officer of Owl Peak Labs, a Biotechnology startup based in Charlottesville, VA working to create innovative in-home colorectal cancer screening solutions.
Dr. Michelle Morse is the inaugural Chief Medical Officer and Deputy Commissioner for the Center for Health Equity and Community Wellness (CHECW) at the NYC Department of Health and Mental Hygiene (NYCDOHMH) where she leads the agency’s work in bridging public health and health care to reduce health inequities, guiding CHECW’s place-based and cross-cutting health equity programs, and serving as a key liaison to clinicians and clinical leaders across New York City.
Dr. Morse is an internal medicine and public health doctor who works to achieve health equity through global solidarity, social medicine and anti-racism education, and activism. She is a general internal medicine physician, part-time hospitalist at Kings County Hospital, Co-Founder of EqualHealth, and Assistant Professor at Harvard Medical School.
Dr. Morse’s continued commitment to advancing health equity and justice is informed by her experience in leadership roles as Deputy Chief Medical Officer of Partners In Heath, as a Soros Equality Fellow launching a global Campaign Against Racism and as a Robert Wood Johnson Health Policy fellow with the Ways and Means Committee in the U.S. House of Representatives.